Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

29.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
29.9K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

3.6K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.6K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

2.6K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.6K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

2.2K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

14
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
14
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

4
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
4

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic Accuracy of Arm Conicity to Detect Inaccurate Non-Invasive Blood Pressure Measurement in Obese Patients.

Acta anaesthesiologica Scandinavica·2026
Same author

Confirmatory Testing for Primary Aldosteronism: Setting the Record Straight Under New Guidelines.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Hypertension and primary aldosteronism diagnosis in hospitalized patients: an observation from public hospitals in Victoria, Australia.

Endocrine·2026
Same author

The not-so-shortcomings of seated saline suppression testing in primary aldosteronism.

European journal of endocrinology·2025
Same author

Investigation of the possible cause of over-estimation of human aldosterone in plasma, using a unique, non-synthetic human aldosterone-free matrix.

Clinical chemistry and laboratory medicine·2025
Same author

Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline.

The Journal of clinical endocrinology and metabolism·2025
Same journal

The Extra X Chromosome and Autoimmune Susceptibility in Klinefelter Syndrome.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Pathophysiology-Based Classification of Male Infertility: Evidence from an 800-patient Prospective Cohort.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Parathyroid Carcinoma: From Molecular Pathogenesis to Multidisciplinary Management.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Genetic and Clinical Factors Associated With Metformin Plasma Concentrations Following an Acute Metformin Challenge.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Continuous glucose monitoring-derived time in range is associated with changes in arterial stiffness in type 2 diabetes.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Association of the Primary Aldosteronism Severity Classification with Lateralization and Treatment Outcomes.

The Journal of clinical endocrinology and metabolism·2026
See all related articles

Related Experiment Video

Updated: Apr 22, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

26.5K

Update in primary aldosteronism.

Michael Stowasser1

  • 1Hypertension Unit, University of Queensland School of Medicine, Princess Alexandra Hospital, Woolloongabba Brisbane 4102, Australia. m.stowasser@uq.edu.au

The Journal of Clinical Endocrinology and Metabolism
|September 10, 2009
PubMed
Summary
This summary is machine-generated.

Primary aldosteronism (PA) affects up to 10% of hypertensive patients and causes significant cardiovascular issues. Early detection and specific treatment of PA can reduce associated morbidity and mortality.

More Related Videos

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

9.7K
Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

7.9K

Related Experiment Videos

Last Updated: Apr 22, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

26.5K
Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

9.7K
Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

7.9K

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Hypertension Research

Background:

  • Primary aldosteronism (PA) is increasingly recognized as a common condition, affecting 5-10% of hypertensive individuals.
  • Aldosterone excess in PA leads to adverse cardiovascular outcomes beyond just hypertension.
  • Recent research highlights the clinical significance and therapeutic implications of PA.

Purpose of the Study:

  • To summarize recent research advancements in primary aldosteronism.
  • To emphasize the importance of systematic screening, diagnosis, and specific treatment for PA.
  • To discuss new developments in PA management and diagnostics.

Main Methods:

  • Review of current research on primary aldosteronism.
  • Analysis of studies demonstrating PA's impact on cardiovascular morbidity and mortality.
  • Evaluation of treatment efficacy and diagnostic refinement.

Main Results:

  • Patients with PA exhibit higher morbidity compared to other hypertensive groups, independent of blood pressure.
  • Specific therapies targeting aldosterone excess improve outcomes in PA patients.
  • Ongoing research focuses on refining diagnostic tools and understanding genetic factors in PA.

Conclusions:

  • Primary aldosteronism is a prevalent and treatable cause of cardiovascular disease.
  • Systematic detection and specific management of PA are crucial for improving patient outcomes.
  • Further research is refining diagnostic approaches and exploring genetic underpinnings of PA.